[{"Assets_0_Q2_USD":5348967000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":353983000.0,"NetIncomeLoss_1_Q2_USD":92321000.0,"NetIncomeLoss_2_Q2_USD":138312000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":61438000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":61309000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":60177000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":60053000.0,"StockholdersEquity_0_Q2_USD":2869752000.0,"EarningsPerShareBasic_1_Q2_USD":1.53,"EarningsPerShareBasic_2_Q2_USD":2.3,"EarningsPerShareDiluted_1_Q2_USD":1.5,"EarningsPerShareDiluted_2_Q2_USD":2.26,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":500479000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":945092000.0,"Ticker":"JAZZ","CIK":"1232524","name":"JAZZ PHARMACEUTICALS PLC","OfficialName":"Jazz Pharmaceuticals plc Common Stock (Ireland)","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"10281986580.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180807"}]